“NETs – Why this master of disguise needs careful handling”
A fantastic INCA inspired article in Cancer World. Sophie Fessl hears from patients and experts about why specialist NET services are so important. Great work to all other contributors.
Recent News
Primary Care Society for Gastroenterology Podcast Episode on Neuroendocrine Cancer
As part of our ‘Spotlight on Neuroendocrine Cancer’ campaign, we aim to raise awareness of neuroendocrine cancer among healthcare professionals. We are delighted that this month the Primary Care Society of Gastroenterology has featured neuroendocrine cancer on their...
Neuroendocrine Cancer Surgical Specialty Lead (SSL) Appointed
- As part of our ‘Advancing Neuroendocrine Cancer Research’ campaign, we are delighted to announce the appointment of a neuroendocrine cancer Surgical Specialty Lead (SSL). This is the first time such a role has been established specifically for neuroendocrine cancer,...
NETTER-2 Study Results: Looking Beyond The headlines.
The latest breakthrough in neuroendocrine cancer treatment comes from the NETTER-2 trial, where Lutetium (177Lu) oxodotreotide, a radio-labeled somatostatin analog, has shown remarkable success in treating high-grade advanced gastroenteropancreatic neuroendocrine...